ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Minimizing Energy Demand in the Conversion of Levulinic Acid to γ‑Valerolactone via Photothermal Catalysis Using Raney Ni.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Decoding Solvent Effects in Electrocatalytic Biomass Valorization: Levulinic Acid to γ‑Valerolactone.ACS sustainable chemistry & engineering · 2026Article
- Minimizing Energy Demand in the Conversion of Levulinic Acid to γ‑Valerolactone via Photothermal Catalysis Using Raney Ni.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The valorization of lignocellulosic wastes emerges as a prime strategy to mitigate the global carbon footprint. Among the multiple biomass derivatives, γ-valerolactone is particularly attractive as precursor of high-value chemicals, biofuel, green solvent or perfumery. γ-Valerolactone can be synthesized through a hydrogenation reaction from levulinic acid, obtained from cellulose. However, the high energy requirements of this synthetic pathway have hindered its industrial viability. To drastically reduce the reaction energy requirements, here a novel synthetic strategy, based on solvothermal-photothermal processes using cost-effective Raney-Ni as photothermal catalyst, is proposed. First, the use of hydrogen gas is avoided by selecting isopropanol as a safer and greener H-source. Second, a photothermocatalytic process is used to minimize the reaction temperature and time with respect to conventional reactions. This approach exploits the broadband optical absorption of the Raney®-Ni, due to its highly damped plasmonic behavior, to achieve fast and efficient catalyst heating inside the reactor. The photothermal reaction required less than 2 h and just 132 °C to reach over 95% conversion, thereby drastically reducing the reaction time and energy consumption compared to conventional reactions. Importantly, these conditions granted high catalyst reusability. This solvothermal-photothermal approach could offer a sustainable alternative for the industrial production of γ-valerolactone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.